Content area
Full Text
Support Care Cancer (2013) 21:14611474 DOI 10.1007/s00520-013-1732-8
REVIEW ARTICLE
Pharmacological and non-hormonal treatment of hot flashesin breast cancer survivors: CEPO review and recommendations
Sylvain LEsprance & Suzanne Frenette & Anne Dionne &
Jean-Yves Dionne & Comit de lvolution des pratiques en oncologie (CEPO)
Received: 18 September 2012 /Accepted: 28 January 2013 /Published online: 23 February 2013 # Springer-Verlag Berlin Heidelberg 2013
AbstractPurpose Breast cancer patients frequently report hot flashes. Given that conventional hormone replacement
therapy is generally contraindicated for them, other therapeutic modalities must be considered. The purpose of this review was to develop evidence-based recommendations on
Members of the Comit de lvolution des pratiques en oncologie (CEPO): Karine Almanric B.Pharm./M.Sc./BCOP, Hpital Citde la Sant de Laval; Gino Boily Ph.D., CEPO; Philippe BouchardB.Pharm./M.Sc./BCOP, Hpital Maisonneuve-Rosemont; Jim Boulanger Ph.D, CEPO; Ghislain Cournoyer MD, Hpital rgional de Saint-Jrme (CSSS de Saint-Jrme); Flix Couture MD, Htel-Dieu de Qubec (CHU de Qubec); Suzanne Frenette B.Pharm./M.Sc./BCOP, Hpital Maisonneuve-Rosemont; Normand Gervais MD, Centre hospitalier rgional du Grand-Portage (CSSS de Rivire-du-Loup); Stphanie Goulet Ph.D., Direction qubcoise de cancrologie (MSSS); Marie-Pascale Guay B.Pharm./M.Sc./BCOP, Jewish General Hospital (MUHC); Mlanie Kavanagh Ph.D., Direction qubcoise de cancrologie (MSSS); Sylvain LEsprance Ph.D., CEPO; Julie Lemieux MD, Hpital du Saint-Sacrement (CHU de Qubec); Bernard Lesprance MD, Hpital du Sacr-Cur de Montral; Nathalie Letarte B.Pharm./M.Sc./BCOP, Hpital Notre-Dame (CHUM); Mlanie Morneau M.Sc./ MBA, Direction qubcoise de cancrologie (MSSS); Jean-Franois Ouellet MD, Htel-Dieu de Qubec (CHU de Quebec); Gilles Pineau MD, INESSS; Raghu Rajan MD, Montreal General Hospital (MUHC); Isabelle Roy MD, Hpital Notre-Dame (CHUM); Benot Samson MD, Hpital Charles LeMoyne; Lucas Sideris MD, Hpital Maisonneuve-Rosemont; Lucie Surprenant B.Pharm./M.Sc./BCOP, Centre hospitalier St. Marys; Franois Vincent MD, Pavillon Sainte-Marie (CSSS de Trois-Rivires).
S. LEspranceComit de lvolution des pratiques en oncologie, 1195, avenue Lavigerie, suite 100,Qubec, Qubec, Canada G1V 4N3
S. Frenette (*)
Department of Pharmacy, Hpital Maisonneuve-Rosemont, 5415, boulevard de lAssomption,Montral, Qubec, Canada H1T 2M4e-mail: [email protected]
A. DionneDepartment of Pharmacy, Hpital du St-Sacrement (CHU de Qubec), 1050, chemin Sainte-Foy, Qubec, Qubec, Canada G1S 4L8
J.-Y. Dionne30, avenue Henley,Mont-Royal, Qubec, Canada H3P 1V3
Comit de lvolution des pratiques en oncologie (CEPO) Direction qubcoise de cancrologie,Ministre de la Sant et des Services sociaux du Qubec, 1075, chemin Ste-Foy, 7e tage,Qubec, Qubec, Canada, G1S 2M1
1462 Support Care Cancer (2013) 21:14611474
non-hormonal pharmacological interventions, including...